Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient

被引：4
|
作者：
Kiykim, AA [1 ]
Ozer, C
Yildiz, A
Tiftik, N
Senli, M
Kelebek, E
Doruk, E
Akbay, E
机构：
[1] Univ Mersin, Fac Med, Dept Internal Med, Div Nephrol, TR-33079 Mersin, Turkey
[2] Univ Mersin, Fac Med, Dept Radiol, TR-33079 Mersin, Turkey
[3] Univ Mersin, Fac Med, Dept Internal Med, Div Hematol, TR-33079 Mersin, Turkey
[4] Univ Mersin, Fac Med, Dept Urol, TR-33079 Mersin, Turkey
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2004年 / 19卷 / 10期
关键词：
haemolytic-uraemic syndrome; tacrolimus; transplant renal artery thrombosis;
D O I：
10.1093/ndt/gfh375
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：2653 / 2656
页数：4
相关论文
共 47 条
  • [41] Renal Transplant from Living Donor in a Patient of Very High Surgical Risks Due to Takayasu Disease and Several Course of Vascular Thrombosis
    Jimenez, Sara
    Maria Fernandez, Ana
    Galeano, Cristina
    Elias, Sandra
    Javier Burgos, Francisco
    Gomez, Victoria
    Liano, Fernando
    TRANSPLANTATION, 2018, 102 : S546 - S546
  • [42] Kidney transplant with multiple renal artery grafts from deceased donors: are long-term graft and patient survival compromised?
    Laouad, Inass
    Bretagnol, Anne
    Fabre, Elodie
    Halimi, Jean-Michel
    Al-Najjar, Azmi
    Boutin, Jean-Michel
    Bruyere, Franck
    Nivet, Hubert
    Lebranchu, Yvon
    Buechler, Matthias
    PROGRESS IN TRANSPLANTATION, 2012, 22 (01) : 102 - 109
  • [43] Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome
    Tatapudi, Vasishta S.
    Lonze, Bonnie E.
    Wu, Ming
    Montgomery, Robert A.
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2018, 8 (01): : 10 - 19
  • [44] One case report of intervention in immunosuppressive agents convertion from cyclosporine to tacrolimus in a renal transplant patient harboring CYP3A5*3/*3 genotype by clinical pharmacist
    Wang, Xue-bin
    Wang, Zhuo
    Yang, Qing
    Xiao, Cheng-wu
    Zhang, Yue
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 40 - 40
  • [45] Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO)
    Hugo, Christian
    Weihprecht, Horst
    Banas, Bernhard
    Schroppel, Bernd
    Jank, Sabine
    Arns, Wolfgang
    Schenker, Peter
    Rath, Thomas
    Hergesell, Olaf
    Feldkamp, Thorsten
    Hermann, Birgit
    Schiffer, Mario
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (05) : 1484 - 1493
  • [46] IMPROVEMENT IN RENAL FUNCTION FOLLOWING CONVERSION FROM LOW-DOSE MYCOPHENOLATE ACID TO HIGHER-DOSE ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) WITH CONCOMITANT TACROLIMUS REDUCTION IN MAINTENANCE KIDNEY TRANSPLANT RECIPIENTS
    Kamar, Nassim
    Mariat, Christophe
    Albano, Laetitia
    Villemain, Florence
    Moal, Marie-Christine
    Ladriere, Marc
    Barrou, Benoit
    Ducloux, Didier
    Quere, Stephane
    Di Giambattista, Fabienne
    Berthoux, Francois
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2009, 22 : 78 - 78
  • [47] Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant
    Guazzo, Raffaella
    Fischer, Anja
    Vannucchi, Margherita
    Fabbri, Alberto
    Garosi, Guido
    Granai, Massimo
    Tripodi, Sergio Antonio
    Oehl-Huber, Kathrin
    Bens, Susanne
    Moawia, Abubakar
    Cencini, Emanuele
    Lazzi, Stefano
    Siebert, Reiner
    Leoncini, Lorenzo
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 266
12345